WeVote
Log In

Bill

Bill

HB 3013

Medical marijuana; requiring final harvest and production batch samples to be tested for certain pesticide analytes; effective date.

2026 Regular Session Introduced by Jacob Rosecrants

Oklahoma would require medical marijuana producers to test final batches for specific pesticide residues, enhancing patient product safety but increasing production costs and compliance complexity.

Referred to Rules
0
WeVote Research Nonpartisan
Bill Summary · HB 3013

Legislative bill overview

HB 3013 would mandate that final harvest and production batches of medical marijuana in Oklahoma undergo testing for specific pesticide residues before distribution. The bill establishes quality control requirements for cannabis products in the state's medical marijuana program.

Why is this important

Pesticide residue in cannabis products poses genuine health risks to patients, particularly those with compromised immune systems or respiratory conditions. This testing requirement directly affects product safety for the estimated tens of thousands of Oklahoma medical marijuana patients and establishes baseline safety standards for an industry with historically inconsistent regulation.

Potential points of contention

  • Cost and compliance burden: Mandatory testing increases production costs for growers, potentially raising patient prices or reducing cultivator profit margins, which could affect market competitiveness
  • Testing standard specificity: The bill references "certain" pesticide analytes without specifying which ones, creating ambiguity about enforcement and whether standards align with federal EPA guidelines or industry best practices
  • Implementation timeline and capacity: Oklahoma's testing infrastructure may lack sufficient laboratory capacity to process all medical marijuana batches, potentially creating supply chain bottlenecks

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.